Presentation is loading. Please wait.

Presentation is loading. Please wait.

Discharge profile explaining the reasons for discharges in the afternoon during April and May 2014, total discharges observed 109. Discharge profile explaining.

Published byKjetil Ingvaldsen Modified over 5 years ago

Similar presentations

Presentation on theme: "Discharge profile explaining the reasons for discharges in the afternoon during April and May 2014, total discharges observed 109. Discharge profile explaining."— Presentation transcript:

1 Discharge profile explaining the reasons for discharges in the afternoon during April and May 2014, total discharges observed 109. Discharge profile explaining the reasons for discharges in the afternoon during April and May 2014, total discharges observed 109. Amira Mustafa, and Samar Mahgoub BMJ Qual Improv Report 2016;5:u w3772 © 2016, Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to

Download ppt "Discharge profile explaining the reasons for discharges in the afternoon during April and May 2014, total discharges observed 109. Discharge profile explaining."

Similar presentations

Graph comparing baseline data with data collected following PDSA cycle 1 (initial introduction of the checklist). PDSA, plan do study act; IV, intravenous.

Graph comparing baseline data with data collected following PDSA cycle 1 (initial introduction of the checklist). PDSA, plan do study act; IV, intravenous.
Percentage of patients attending for GP steroid review following steroid letter. GP, general practitioner; LTOC, long-term oral corticosteroids. Percentage.

Percentage of patients attending for GP steroid review following steroid letter. GP, general practitioner; LTOC, long-term oral corticosteroids. Percentage.
Summary of project team improvement efforts

Summary of project team improvement efforts
Effect of interventions on % appointments not attended

Effect of interventions on % appointments not attended
Run chart showing outcomes of interventions expressed as percentage of cases with active implantable cardioverter defibrillator (ICD) in situ postmortem. PDSA, Plan-Do-Study-Act.

Run chart showing outcomes of interventions expressed as percentage of cases with active implantable cardioverter defibrillator (ICD) in situ postmortem. PDSA, Plan-Do-Study-Act.
Run chart for measure 2 (adjusted timely morning discharge which is the percentage of patients who left by noon out of those eligible for morning discharge.

Run chart for measure 2 (adjusted timely morning discharge which is the percentage of patients who left by noon out of those eligible for morning discharge.
Outcomes in (A) sepsis-related mortality, (B) sepsis-related length of stay and (C) sepsis-related 30-day readmissions before implementation of the machine.

Outcomes in (A) sepsis-related mortality, (B) sepsis-related length of stay and (C) sepsis-related 30-day readmissions before implementation of the machine.
The poster displayed across the wards and on our Trust intranet

The poster displayed across the wards and on our Trust intranet
Percentage of newborns admitted to neonatal intensive care unit with axillary temperature over 36.5°C on arrival (July 2016–April 2017). Percentage of.

Percentage of newborns admitted to neonatal intensive care unit with axillary temperature over 36.5°C on arrival (July 2016–April 2017). Percentage of.
Percentage of newborns admitted to neonatal intensive care unit with axillary temperature below 36°C on arrival (July 2016–April 2017). Percentage of newborns.

Percentage of newborns admitted to neonatal intensive care unit with axillary temperature below 36°C on arrival (July 2016–April 2017). Percentage of newborns.
Photograph to show surface anatomy identified by Braunstein et al.

Photograph to show surface anatomy identified by Braunstein et al.
This a Pareto chart showing the data obtained from auditing the steps in the discharge process. This a Pareto chart showing the data obtained from auditing.

This a Pareto chart showing the data obtained from auditing the steps in the discharge process. This a Pareto chart showing the data obtained from auditing.
Mortality from CHD and stroke in women and men, by country and year.

Mortality from CHD and stroke in women and men, by country and year.
Fishbone diagram of the cause-and-effect analysis

Fishbone diagram of the cause-and-effect analysis
Burden of sepsis estimated from administrative data using ICD-10AM code preimplementation and postimplementation of sepsis pathway. ICD-10, International 

Burden of sepsis estimated from administrative data using ICD-10AM code preimplementation and postimplementation of sepsis pathway. ICD-10, International 
Figure 4. Run chart for medication dosage as per national asthma care guideline. Figure 4. Run chart for medication dosage as per national asthma care.

Figure 4. Run chart for medication dosage as per national asthma care guideline. Figure 4. Run chart for medication dosage as per national asthma care.
Diagnoses of CD per 1000 of the population for 2410 patients by biopsy (1689) and serology (721) in Derby hospitals by gender and age bands. Diagnoses.

Diagnoses of CD per 1000 of the population for 2410 patients by biopsy (1689) and serology (721) in Derby hospitals by gender and age bands. Diagnoses.
Schematic representation of referral process (1a) and suggested areas to improve the referral process of the Emergency clinic (1b). Schematic representation.

Schematic representation of referral process (1a) and suggested areas to improve the referral process of the Emergency clinic (1b). Schematic representation.
COAST (COAgulopathy in Severe Trauma) prehospital score used in PATCH clinical trial. COAST (COAgulopathy in Severe Trauma) prehospital score used in PATCH.

COAST (COAgulopathy in Severe Trauma) prehospital score used in PATCH clinical trial. COAST (COAgulopathy in Severe Trauma) prehospital score used in PATCH.
Summary results of initial neutropenic sepsis management in Belfast Trust Oncology and Haematology patients from June 2011 to present. Summary results.

Summary results of initial neutropenic sepsis management in Belfast Trust Oncology and Haematology patients from June 2011 to present. Summary results.

Similar presentations

Ads by Google